ASX - By Stock
|
IMM |
Re:
Ann: Immutep to present Phase IIb breast cancer data at ESMO 2022
|
|
Vivo
|
18 |
9.2K |
2 |
18/03/22 |
18/03/22 |
ASX - By Stock
|
18
|
9.2K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
6 |
18/03/22 |
18/03/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
1 |
18/03/22 |
18/03/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
13 |
18/03/22 |
18/03/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
13
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
8 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
0 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
9 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep receives FDA feedback for Efti development in MBC
|
|
Vivo
|
43 |
21K |
7 |
13/03/22 |
13/03/22 |
ASX - By Stock
|
43
|
21K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep receives FDA feedback for Efti development in MBC
|
|
Vivo
|
43 |
21K |
2 |
12/03/22 |
12/03/22 |
ASX - By Stock
|
43
|
21K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep receives FDA feedback for Efti development in MBC
|
|
Vivo
|
43 |
21K |
7 |
12/03/22 |
12/03/22 |
ASX - By Stock
|
43
|
21K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep receives FDA feedback for Efti development in MBC
|
|
Vivo
|
43 |
21K |
0 |
11/03/22 |
11/03/22 |
ASX - By Stock
|
43
|
21K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep receives FDA feedback for Efti development in MBC
|
|
Vivo
|
43 |
21K |
10 |
10/03/22 |
10/03/22 |
ASX - By Stock
|
43
|
21K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Vivo
|
382 |
194K |
5 |
07/02/22 |
07/02/22 |
ASX - By Stock
|
382
|
194K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Vivo
|
382 |
194K |
1 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
382
|
194K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Quarterly Activities Report and Appendix 4C
|
|
Vivo
|
21 |
8.0K |
15 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
21
|
8.0K
|
15
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Quarterly Activities Report and Appendix 4C
|
|
Vivo
|
21 |
8.0K |
7 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
21
|
8.0K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Quarterly Activities Report and Appendix 4C
|
|
Vivo
|
21 |
8.0K |
1 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
21
|
8.0K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Quarterly Activities Report and Appendix 4C
|
|
Vivo
|
21 |
8.0K |
8 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
21
|
8.0K
|
8
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Vivo
|
33K |
16M |
0 |
24/01/22 |
24/01/22 |
Charts
|
33K
|
16M
|
0
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Vivo
|
33K |
16M |
4 |
24/01/22 |
24/01/22 |
Charts
|
33K
|
16M
|
4
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Response to ASX Query
|
|
Vivo
|
11 |
4.0K |
2 |
24/01/22 |
24/01/22 |
ASX - By Stock
|
11
|
4.0K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
CLSA initiate on Immutep with Target price of $1.19
|
|
Vivo
|
35 |
20K |
0 |
21/01/22 |
21/01/22 |
ASX - By Stock
|
35
|
20K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Vivo
|
382 |
194K |
6 |
21/01/22 |
21/01/22 |
ASX - By Stock
|
382
|
194K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Vivo
|
382 |
194K |
3 |
21/01/22 |
21/01/22 |
ASX - By Stock
|
382
|
194K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Vivo
|
382 |
194K |
4 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
382
|
194K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
5 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
2 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Vivo
|
382 |
194K |
12 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
382
|
194K
|
12
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Vivo
|
382 |
194K |
4 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
382
|
194K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Vivo
|
382 |
194K |
3 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
382
|
194K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Vivo
|
382 |
194K |
15 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
382
|
194K
|
15
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Vivo
|
382 |
194K |
5 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
382
|
194K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
15 |
11/01/22 |
11/01/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
15
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
4 |
11/01/22 |
11/01/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Vivo
|
382 |
194K |
16 |
10/01/22 |
10/01/22 |
ASX - By Stock
|
382
|
194K
|
16
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Vivo
|
382 |
194K |
13 |
10/01/22 |
10/01/22 |
ASX - By Stock
|
382
|
194K
|
13
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
25 |
10/01/22 |
10/01/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
25
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
2 |
09/01/22 |
09/01/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
0 |
05/01/22 |
05/01/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Change in substantial holding
|
|
Vivo
|
4 |
2.7K |
4 |
05/01/22 |
05/01/22 |
ASX - By Stock
|
4
|
2.7K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
0 |
04/01/22 |
04/01/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
0
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Vivo
|
33K |
16M |
8 |
02/01/22 |
02/01/22 |
Charts
|
33K
|
16M
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
5 |
01/01/22 |
01/01/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
2 |
01/01/22 |
01/01/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
4 |
01/01/22 |
01/01/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
4
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Vivo
|
33K |
16M |
4 |
31/12/21 |
31/12/21 |
Charts
|
33K
|
16M
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Vivo
|
382 |
194K |
6 |
28/12/21 |
28/12/21 |
ASX - By Stock
|
382
|
194K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Vivo
|
382 |
194K |
13 |
27/12/21 |
27/12/21 |
ASX - By Stock
|
382
|
194K
|
13
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
3 |
24/12/21 |
24/12/21 |
ASX - By Stock
|
2.7K
|
1.1M
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Vivo
|
2.7K |
1.1M |
1 |
23/12/21 |
23/12/21 |
ASX - By Stock
|
2.7K
|
1.1M
|
1
|
|